Scarica l'app Stockscreener
3.09
9.96%
0.28
Precedente Chiudi:
$2.81
Aprire:
$2.79
Volume 24 ore:
118.00K
Relative Volume:
0.31
Capitalizzazione di mercato:
$3.16M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.28%
1M Prestazione:
-36.82%
6M Prestazione:
-84.65%
1 anno Prestazione:
-95.15%
Intervallo 1D:
$2.79
$3.10
Intervallo di 1 settimana:
$2.73
$3.42
Portata 52W:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Nome
Psyence Biomedical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
3.09 | 2.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks
Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative
Psyence, PsyLabs deal locks in psychedelic drug supply while preserving cash - Stock Titan
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - TipRanks
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Psyence Biomedical announces settlement of shareholder litigation - TipRanks
Psyence Biomed announces settlement of shareholder litigation - marketscreener.com
Psyence Biomedical Ltd. Reaches Settlement Agreement with KAOS Capital Ltd. to Resolve Shareholder Claims - Quiver Quantitative
Psyence BioMed Announces Settlement of Shareholder Litigation - ChartMill
Published on: 2026-02-11 15:38:29 - mfd.ru
Is Psyence Biomedical Ltd. stock forming a triangle patternWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru
Revenue Check: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500July 2025 Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Final Week: Is Xenon Pharmaceuticals Inc a play on infrastructure spendingBond Market & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Buy Signal: Will BMEA face regulatory challenges2025 Market Outlook & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Sentiment: Whats the beta of Psyence Biomedical Ltd stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Aug Breakouts: Is Psyence Biomedical Ltd. Equity Warrant forming a double bottomJuly 2025 Snapshot & Capital Efficiency Focused Ideas - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyInsider Selling & Capital Protection Trading Alerts - mfd.ru
Analyst Calls: Will Psyence Biomedical Ltd benefit from rate cuts2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Psyence Biomedical Delays Reverse Stock Split Implementation - Intellectia AI
Quarterly Trades: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Market WrapUp & Reliable Price Action Trade Plans - baoquankhu1.vn
Growth Value: Is Psyence Biomedical Ltd Equity Warrant in a long term uptrendJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Recap Report: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periods - baoquankhu1.vn
Published on: 2026-01-31 23:30:18 - baoquankhu1.vn
Trend Recap: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocksQuarterly Trade Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Downgrade Watch: Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025 - mfd.ru
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Australia
Will Psyence Biomedical Ltd. benefit from seasonalityTrade Risk Assessment & Reliable Entry Point Alerts - mfd.ru
What are the analyst revisions for NDRAIs Psyence Biomedical Ltd. stock a good investment in YEAR2025 Year in Review & Consistent Growth Equity Picks - mfd.ru
Psyence Biomedical Sets February 2 Effective Date for 1-for-6.25 Reverse Stock Split - TipRanks
Psyence BioMed (NASDAQ: PBM) plans 1-for-6.25 reverse stock split in 2026 - Stock Titan
Psyence Delays Effective Date For 1-for-6.25 Reverse Stock Split; Stock Down - Nasdaq
Psyence Biomedical announces 1-for-6.25 share consolidation - Investing.com
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split - The Manila Times
Psyence Biomedical Ltd. Announces Delayed Implementation of 1-for-6.25 Share Consolidation Effective February 2, 2026 - Quiver Quantitative
Psyence Biomedical Reschedules Shareholder Meeting After Quorum Shortfall - TipRanks
Press Release: Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - 富途牛牛
NEWCOURT ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com
NEWCOURT ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - marketscreener.com
Psyence Biomedical announces milestone in natural ibogaine HCl production - MSN
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - The Manila Times
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - GlobeNewswire Inc.
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence Biomedical postpones planned reverse stock split By Investing.com - Investing.com South Africa
Psyence Biomedical announces postponement of reverse stock split effective date - TipRanks
Psyence Biomedical postpones planned reverse stock split - Investing.com
Psyence Biomedical Ltd. Announces Postponement of Reverse Stock Split Effective Date - Quiver Quantitative
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date - GlobeNewswire
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionConsumer Goods Stocks & Free Powerful Profit Generation - Bollywood Helpline
Can Psyence Biomedical Ltd. outperform in the next rally2025 Volatility Report & Weekly Watchlist for Consistent Profits - bollywoodhelpline.com
Psyence Biomedical Ltd Azioni (PBM) Dati Finanziari
Non sono disponibili dati finanziari per Psyence Biomedical Ltd (PBM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):